256 related articles for article (PubMed ID: 28713071)
1. Association of Interleukin-2-330T/G and Interleukin-10-1082A/G Genetic Polymorphisms with B-Cell Non-Hodgkin Lymphoma in a Cohort of Egyptians.
Abdel Rahman HA; Khorshied MM; Reda Khorshid OM; Mourad HM
Turk J Haematol; 2018 May; 35(2):99-108. PubMed ID: 28713071
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 2 and 9 genetic polymorphisms and the susceptibility to B cell Non-Hodgkin Lymphoma in Egypt.
Rahman HA; Khorshied MM; Khorshid OM; Mahgoub SM
Ann Hematol; 2014 Nov; 93(11):1859-65. PubMed ID: 24912772
[TBL] [Abstract][Full Text] [Related]
3. CD38 and interleukin 6 gene polymorphism in egyptians with diffuse large B-cell lymphoma (DLBCL).
Talaat RM; Abdel-Aziz AM; El-Maadawy EA; Abdel-Bary N
Immunol Invest; 2015; 44(3):265-78. PubMed ID: 25564959
[TBL] [Abstract][Full Text] [Related]
4. Relationship between IL-10 gene polymorphisms and the risk of non-Hodgkin lymphoma: A meta-analysis.
Li G; Li D
Hum Immunol; 2016 May; 77(5):418-25. PubMed ID: 27006334
[TBL] [Abstract][Full Text] [Related]
5. Association of Interleukin-10 -3575T>A and -1082A>G polymorphisms with non-Hodgkin lymphoma susceptibility: a comprehensive review and meta-analysis.
Zhang Y; Xia ZG; Zhu JH; Chen MB; Wang TM; Shen WX; He J
Mol Genet Genomics; 2015 Dec; 290(6):2063-73. PubMed ID: 25977148
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations in tumor ecrosis factor related apoptosis-inducing ligand receptor-1 (TRAIL-R1) gene and the susceptibility to b-cell non-hodgkin lymphoma (B-NHL) in Egypt.
Khorshied M; Soliman N; Khorshid O; Bakr S
Cancer Biomark; 2021; 32(4):451-458. PubMed ID: 34275891
[TBL] [Abstract][Full Text] [Related]
7. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM
Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 10 gene -1082A/G polymorphism is associated with osteosarcoma risk and poor outcomes in the Chinese population.
Cui Y; Zhu JJ; Ma CB; Cui K; Wang F; Ni SH; Zhang ZY
Tumour Biol; 2016 Apr; 37(4):4517-22. PubMed ID: 26503210
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-10 -592C/A, but not -1082A/G promoter single nucleotide polymorphism, is associated with a decreased risk of colorectal cancer in an ethnic Kashmiri population: a case-control study.
Banday MZ; Sameer AS; Chowdri NA; Haq E
Eur J Cancer Prev; 2017 Nov; 26(6):476-490. PubMed ID: 28538040
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-2-330T/G and Interleukin-10-1082A/G Genetic Polymorphisms and B-Cell Non-Hodgkin Lymphoma.
Joob B; Wiwanitkit V
Turk J Haematol; 2018 Nov; 35(4):301-302. PubMed ID: 30187886
[No Abstract] [Full Text] [Related]
11. Interleukin-10 - 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection.
Persico M; Capasso M; Persico E; Masarone M; Renzo Ad; Spano D; Bruno S; Iolascon A
J Hepatol; 2006 Dec; 45(6):779-85. PubMed ID: 17049666
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 2 gene polymorphisms are associated with non-Hodgkin lymphoma.
Song H; Chen L; Cha Z; Bai J
DNA Cell Biol; 2012 Jul; 31(7):1279-84. PubMed ID: 22472080
[TBL] [Abstract][Full Text] [Related]
13. The association between hepatitis C virus infection, genetic polymorphisms of oxidative stress genes and B-cell non-Hodgkin's lymphoma risk in Egypt.
Farawela H; Khorshied M; Shaheen I; Gouda H; Nasef A; Abulata N; Mahmoud HA; Zawam HM; Mousa SM
Infect Genet Evol; 2012 Aug; 12(6):1189-94. PubMed ID: 22522002
[TBL] [Abstract][Full Text] [Related]
14. Association of cytotoxic T-lymphocyte antigen 4 genetic polymorphism, hepatitis C viral infection and B-cell non-Hodgkin lymphoma: an Egyptian study.
Khorshied MM; Gouda HM; Khorshid OM
Leuk Lymphoma; 2014 May; 55(5):1061-6. PubMed ID: 23829277
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
16. Investigation on the association between inerleukin-10 -592C/A, 819C/T and -1082A/G gene polymorphisms and development of diabetic nephrophathy.
Yin Q; Zhai Q; Wang D; Hai J; Cao M; Wang J; Wang T
Int J Clin Exp Pathol; 2015; 8(11):15216-21. PubMed ID: 26823869
[TBL] [Abstract][Full Text] [Related]
17. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
Kube D; Hua TD; von Bonin F; Schoof N; Zeynalova S; Klöss M; Gocht D; Potthoff B; Tzvetkov M; Brockmöller J; Löffler M; Pfreundschuh M; Trümper L
Clin Cancer Res; 2008 Jun; 14(12):3777-84. PubMed ID: 18559596
[TBL] [Abstract][Full Text] [Related]
18. The interleukin-10-1082A>G polymorphism and lymphoma risk: a meta-analysis.
Yu X; Chen B; Cheng J; Gao C; Zhang X; Bao W
Cancer Biomark; 2014; 14(5):381-8. PubMed ID: 25171480
[TBL] [Abstract][Full Text] [Related]
19. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
[TBL] [Abstract][Full Text] [Related]
20. The association between -330T/G polymorphism of interleukin 2 gene and bladder cancer.
Shen Y; Liu Y; Liu S; Zhang A
DNA Cell Biol; 2012 Jun; 31(6):983-7. PubMed ID: 22242968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]